Form 4 Filing for Autolus Therapeutics plc

This filing details a Form 4 submission by Robert Iannone, a director at Autolus Therapeutics plc, on June 29, 2026. The transaction involved the acquisition of 31,667 Restricted Stock Units (RSUs) and 47,500 share options. The RSUs, representing contingent rights to one American Depositary Share (ADS) each, vest on June 29, 2027. The share options, with an exercise price of $1.61 per share, vest in twelve equal monthly installments starting July 29, 2026. Mr. Iannone holds these securities directly. The ADSs are underpinned by ordinary shares of the company. The filing was signed on July 1, 2026.